Insmed Incorporated (INSM)

Insmed Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-1,277	-913.77	-749.57	-481.53	-434.65
Depreciation & Amortization	19.16	13.73	13.29	12.29	15.26
Stock-Based Compensation	152.71	96.84	74.78	57.69	46.02
Other Adjustments	250.19	122.51	164.47	4.54	68.65
Change in Receivables	-88.31	-12.93	-11.96	-6.42	-8.12
Changes in Inventories	-31.52	-17.04	-13.61	-1.71	-17.46
Changes in Accounts Payable	100.07	44.59	15.16	50.01	-7.58
Changes in Other Operating Activities	-60.55	-17.79	-28.8	-35.3	-25.43
Operating Cash Flow	-935.01	-683.88	-536.25	-400.44	-363.3
Capital Expenditures	-32.56	-21.92	-13.29	-9.88	-7.29
Purchases of Investments	-2,092	-1,577	-588.73	-99.71	-50.29
Proceeds from Sale of Investments	2,090	1,016	375	75	-
Payments for Business Acquisitions	-	-	-	-	-6.7
Other Investing Activities	-	-	3.42	-	-
Investing Cash Flow	-64.58	-583.18	-223.6	-34.58	-64.29
Long-Term Debt Issued	-	-	-	500	575
Long-Term Debt Repaid	-4.93	-2.61	-1.22	-0.6	-238.66
Net Long-Term Debt Issued (Repaid)	-4.93	-2.61	-1.22	499.4	336.34
Issuance of Common Stock	959	1,197	170.87	311.66	291.92
Net Common Stock Issued (Repurchased)	959	1,197	170.87	311.66	291.92
Other Financing Activities	-	-3.74	-1.22	-17.78	-15.72
Financing Cash Flow	954.07	1,341	168.44	793.27	612.55
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.93	-1.31	-0.25	-1	-0.93
Net Cash Flow	-44.59	72.66	-591.66	357.25	184.03
Free Cash Flow	-967.58	-705.81	-549.54	-410.32	-370.59
FCF Margin	-159.55%	-194.06%	-180.05%	-167.23%	-196.64%
Free Cash Flow Per Share	-4.86	-4.30	-3.91	-3.33	-3.31
Levered Free Cash Flow	-1,287	-914.83	-778.04	33.28	-140.8
Unlevered Free Cash Flow	-1,257	-880.27	-739.31	-443.23	-416.07

Updated Feb 19, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q